Biogen's former R&D boss resurfaces on board of California biotech
Biogen's former R&D boss resurfaces on board of California biotech
Alfred W. Sandrock, Jr., M.D., Ph.D., Joins Verge Genomics’ Board of Directors
https://www.biospace.com/article/bayer-poaches-gsk-s-christine-roth-editas-terminates-cmo-other-executive-moves
CVS inks a deal with Medable to enroll more patients in clinical trials
Al Sandrock notches another post-Biogen role — and it's taking him right back onto familiar ground
Alfred W. Sandrock, Jr., M.D., Ph.D., Joins Verge Genomics’ Board of Directors
Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022
Biotech Startup Verge Genomics Collects $98 Million
Verge Genomics Secures $98 Million in New Financing
Alice Zhang's 'all-in-human' AI and genomics upstart scores a $98M Series B
Verge Genomics Gets $98M to Take ALS Drug to the Clinic
32nd International Symposium on ALS/MND
32nd International Symposium on ALS/MND
A very delicate balance Could blocking lysosomal gatekeeper PIKfyve slow neurodegeneration?
Discovery Chemistry US
Congratulations to our 2021 Catalyst Award Winners
Verge Genomics Adds Independent Director Andrew Allen, M.D., Ph.D., to its Board of Directors
AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE WEST COAST 2021 SAN FRANCISCO
They Still Live in the Shadow of Theranos’s Elizabeth Holmes
